Publikation: Effects of serotonergic psychedelics on mitochondria : Transdiagnostic implications for mitochondria-related pathologies
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
The use of serotonergic psychedelics has gained increasing attention in research, clinical practice and society. Growing evidence suggests fast-acting, transdiagnostic health benefits of these 5-hydroxytryptamine 2A receptor agonists. Here, we provide a brief overview of their benefits for psychological, cardiovascular, metabolic, neurodegenerative, and immunological pathologies. We then review their effect on mitochondria including mitochondrial biogenesis, functioning and transport. Mitochondrial dysregulation is a transdiagnostic mechanism that contributes to the aforementioned pathologies. Hence, we postulate that psychedelic-induced effects on mitochondria partially underlie their transdiagnostic benefits. Based on this assumption, we propose new treatment indications for psychedelics and that the health benefits induced by psychedelics depend on patient-specific mitochondrial dysregulation.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
FISSLER, Patrick, Anja VANDERSMISSEN, Marco FILIPPI, Rezan Nehir MAVIOGLU, Felix SCHOLKMANN, Alexander KARABATSIAKIS, Rainer KRÄHENMANN, 2023. Effects of serotonergic psychedelics on mitochondria : Transdiagnostic implications for mitochondria-related pathologies. In: Journal of Psychopharmacology. Sage. 2023, 37(7), pp. 679-686. ISSN 0269-8811. eISSN 1461-7285. Available under: doi: 10.1177/02698811231164707BibTex
@article{Fissler2023-04-25Effec-68205, year={2023}, doi={10.1177/02698811231164707}, title={Effects of serotonergic psychedelics on mitochondria : Transdiagnostic implications for mitochondria-related pathologies}, number={7}, volume={37}, issn={0269-8811}, journal={Journal of Psychopharmacology}, pages={679--686}, author={Fissler, Patrick and Vandersmissen, Anja and Filippi, Marco and Mavioglu, Rezan Nehir and Scholkmann, Felix and Karabatsiakis, Alexander and Krähenmann, Rainer} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/68205"> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-11-15T12:41:08Z</dcterms:available> <dc:contributor>Karabatsiakis, Alexander</dc:contributor> <dc:contributor>Krähenmann, Rainer</dc:contributor> <dc:contributor>Mavioglu, Rezan Nehir</dc:contributor> <dc:creator>Krähenmann, Rainer</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-11-15T12:41:08Z</dc:date> <dc:contributor>Fissler, Patrick</dc:contributor> <dcterms:title>Effects of serotonergic psychedelics on mitochondria : Transdiagnostic implications for mitochondria-related pathologies</dcterms:title> <dc:creator>Fissler, Patrick</dc:creator> <dc:creator>Filippi, Marco</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/68205"/> <dc:creator>Mavioglu, Rezan Nehir</dc:creator> <dcterms:abstract>The use of serotonergic psychedelics has gained increasing attention in research, clinical practice and society. Growing evidence suggests fast-acting, transdiagnostic health benefits of these 5-hydroxytryptamine 2A receptor agonists. Here, we provide a brief overview of their benefits for psychological, cardiovascular, metabolic, neurodegenerative, and immunological pathologies. We then review their effect on mitochondria including mitochondrial biogenesis, functioning and transport. Mitochondrial dysregulation is a transdiagnostic mechanism that contributes to the aforementioned pathologies. Hence, we postulate that psychedelic-induced effects on mitochondria partially underlie their transdiagnostic benefits. Based on this assumption, we propose new treatment indications for psychedelics and that the health benefits induced by psychedelics depend on patient-specific mitochondrial dysregulation.</dcterms:abstract> <dc:contributor>Filippi, Marco</dc:contributor> <dc:contributor>Scholkmann, Felix</dc:contributor> <dc:creator>Scholkmann, Felix</dc:creator> <dc:creator>Vandersmissen, Anja</dc:creator> <dc:language>eng</dc:language> <dcterms:issued>2023-04-25</dcterms:issued> <dc:contributor>Vandersmissen, Anja</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:creator>Karabatsiakis, Alexander</dc:creator> </rdf:Description> </rdf:RDF>